Skip to main content

FDA recall, , Moderate risk

Olympus 4K UHD LCD Monitor

The Olympus 4K UHD LCD Monitor can have faulty HDMI and DisplayPort connectors, causing image loss or abnormalities.

What happened

Olympus Corporation of the Americas, located in Center Valley, Pennsylvania, recalled its Olympus 4K UHD LCD Monitor, Model Number OEV321UH, on July 7, 2026. The FDA added the recall to its Enforcement Report on July 20, 2026, and it was in the FDA's weekly enforcement report on July 29, 2026. The recall involved 10 units distributed in California, Florida, New Jersey, Ohio, and Japan.

The agency stated that the HDMI and DisplayPort connectors can become faulty, resulting in image loss or image abnormalities in the electrically powered visual display unit designed for displaying graphical information in color.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the model number and UDI-DI listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Olympus 4K UHD LCD Monitor.

    Model
    • OEV321UH
    UDI-DI
    • 04953170418723

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Ohio, California, New Jersey, Florida and the country of Japan.

Company
Olympus Corporation of the AmericasCenter Valley, Pennsylvania
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99288
Recall number
Z-2761-2026
Quantity recalled
10 units

All recalls from Olympus Corporation of the Americas

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)